Navigation Links
Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference

AdvaMed's First-Ever Medical Technology Conference Brings Together Policy and Innovation Experts

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- A panel of leading health care economists and physician-innovators today highlighted the benefits of advanced medical technology for improving patient care and helping to reduce health care costs. The panel session, entitled "Value of Medical Technology: Innovation, Patients, Society," was part of AdvaMed 2007, the premier medical technology conference and exhibition for business leaders, policymakers, investors, news media, patient advocates, and industry stakeholders from around the world.

The distinguished panel featured Uwe Reinhardt, Ph.D., professor of economics and public affairs at Princeton University; Frank Lichtenberg, Ph.D., Courtney C. Brown Professor of Business at Columbia University; Thomas Fogarty, M.D., physician and inventor; and Martin Malawar, M.D., professor of orthopedic surgery at Georgetown University Medical Center and director of orthopedic oncology at Washington Hospital Center. CNN health care correspondent Val Willingham moderated the panel session.

The panel's wide-ranging discussion touched on a number of topics, including the unique process of medical technology innovation, the role of physicians in that process, and how medical technology adds value to the health care system through greater efficiencies and improved patient outcomes.

"Innovations in diagnostic testing provide physicians with better and more timely information about patients' medical conditions," noted Lichtenberg. "This often results in more appropriate and effective treatment, hence improved outcomes and/or lower medical costs."

Dr. Fogarty, one of the pioneers of minimally invasive surgery, stressed how many different players, including physicians and industry, need to come together to make medical advancements possible. "Medical technology innovation depends on the interface of a complex web of players - industry; academia; regulators, the medical community and others - in order to succeed. Without all these players doing their part, the next generation of treatments will never make it to patients. Whatever we do, we must always keep the patient foremost in our minds," he said.

AdvaMed President and CEO Stephen J. Ubl said that as the debate on health care reform intensifies in the coming months, policymakers need to keep in mind the panelists' lessons on the value medical technology provides. "Innovations that diagnose disease earlier, reduce complications, shorten hospital stays and get people back to living their lives are part of the solution to America's health care challenges, and these types of advancements need to be encouraged to thrive," Ubl said.

Jim Mazzo, Chairman, President and CEO of Advanced Medical Optics and Chair of AdvaMed's Value of Technology Board Committee, agreed. "At no other time in history have we seen such astounding medical progress," Mazzo said. "Our citizens not only deserve the latest in health care technology, it also makes good economic sense to ensure we all have access to the best care possible."

To learn more about how advanced medical technologies improve patients' lives and add real value to the health care system, visit

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

SOURCE AdvaMed Value of Technology
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Web-based reporting credited with states top healthcare ranking
3. Visions, Part II: Preizler sees IT leading incremental health system change
4. Visions: Preizler offers insurers perspective on healthcare IT
5. Federal bill would set healthcare IT standards
6. IRS ruling could speed healthcare technology adoption
7. Bill would provide federal aid for healthcare IT
8. Cardinal Health likes growth potential of Viasys NeuroCare Group
9. DHC 2007: Controlling health IT costs the key to capturing value
10. Siemens health services president calls IT benefits unassailable
11. DHC 2007: Without fuller IT adoption, health costs might drain Americas wealth
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):